Home >> WEBINARS >> Practical considerations and real-world examples: CAP/IASLC/AMP molecular testing guideline updates for NSCLC

Practical considerations and real-world examples: CAP/IASLC/AMP molecular testing guideline updates for NSCLC

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenter Michelle Shiller, DO, MSPT, discusses key updates to the CAP/IASLC/AMP guideline recommendations for molecular testing in patients with NSCLC and the impact of the CAP/IASLC/AMP guideline recommendations on clinical practice illustrated through testing case scenarios. This on-demand webinar originally broadcast on May 9, 2018.

CAP TODAY does not endorse any of the products or services named within. US-19418 Last Updated 4/18

x

Check Also

Homologous recombination deficiency and BRCA testing in ovarian and breast cancer

Webinar presenters Dana Chase, MD,  Michelle Shiller, DO, and Tabetha Sundin, PhD discuss the role of BRCA1/2 mutations in homologous recombination deficiency and carcinogenesis, homologous recombination deficiency as a marker of treatment sensitivity, the testing process for homologous recombination deficiency and BRCA mutations, and the role of BRCA testing in ovarian and breast cancer. This on-demand webinar originally broadcast on October 23, 2018.

X